General indicators
| QI 1 - Number of newly diagnosed cases of endometrial carcinoma treated per center per year | |
| Type | Structural indicator |
| Description | Number of newly diagnosed cases of endometrial carcinoma treated (surgically or not surgically) per center per year. |
| Specifications | Numerator: number of newly diagnosed endometrial carcinoma cases treated per center per year. Denominator: not applicable. |
| Targets | Optimal target: ≥90 Minimum required target: ≥50 |
| QI 2 - Number of endometrial carcinoma primary surgeries (including early and advanced stages) performed per center per year | |
| Type | Structural indicator |
| Description | Primary surgeries, including lymph node assessment, hysterectomy, and cytoreductive surgeries for early and advanced-stage endometrial carcinoma |
| Specifications | Numerator: number of patients undergoing a primary surgery as defined above performed per center per year Denominator: not applicable |
| Targets | Optimal target: ≥80 Minimum required target: ≥50 |
| QI 3 - Surgery performed by a gynecologic oncologist or a trained surgeon specifically dedicated to gynecological cancer management | |
| Type | Process indicator |
| Description | Surgery is performed or supervised by a certified gynecologic oncologist, or in countries where certification is not established, by a trained surgeon dedicated to the management of gynecological cancer (accounting for more than 80% of his or her practice) or having completed an ESGO-certified fellowship |
| Specifications | Numerator: number of patients with endometrial carcinoma operated by a surgical specialist as defined above or supervised by this category Denominator: number of patients with endometrial carcinoma undergoing surgery |
| Target | ≥95% |
| QI 4 - Treatment and/or follow-up plan discussed at a multi-disciplinary team meeting | |
| Type | Process indicator |
| Description | The decision for any therapeutic intervention and/or follow-up plan has been made by a multi-disciplinary team including at least a certified gynecologic oncologist (or in countries where certification is not organized, a trained surgeon dedicated to the management of gynecological cancer (accounting for more than 80% of his or her practice) or having completed an ESGO-certified fellowship), a radiologist, a radiation oncologist, a physician certified to deliver chemotherapy (a gynecologic oncologist and/or a physician with special interest to gynecologic oncology (medical or clinical oncologist)), and a pathologist |
| Specifications | Primary treatment:
Relapse treatment:
|
| Targets | Primary treatment: 90% Relapse treatment: 99% |
| QI 5 - Center participating in ongoing prospective studies in gynecological oncology | |
| Type | Structural indicator |
| Description | The center actively accrues patients in ongoing prospective studies (including notably studies on imaging, translational research, quality of life, and/or tissue procurement) in gynecological oncology. The studies should be approved by an ethical committee |
| Specifications | Numerator: not applicable Denominator: not applicable |
| Targets | Optimal target: participation in ongoing prospective studies in endometrial carcinoma Minimum required target: participation in ongoing prospective studies in gynecological oncology |